Correlation Between Neuropace and 908 Devices

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and 908 Devices at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and 908 Devices into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and 908 Devices, you can compare the effects of market volatilities on Neuropace and 908 Devices and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of 908 Devices. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and 908 Devices.

Diversification Opportunities for Neuropace and 908 Devices

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Neuropace and 908 is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and 908 Devices in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 908 Devices and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with 908 Devices. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 908 Devices has no effect on the direction of Neuropace i.e., Neuropace and 908 Devices go up and down completely randomly.

Pair Corralation between Neuropace and 908 Devices

Given the investment horizon of 90 days Neuropace is expected to generate 1.21 times more return on investment than 908 Devices. However, Neuropace is 1.21 times more volatile than 908 Devices. It trades about 0.1 of its potential returns per unit of risk. 908 Devices is currently generating about -0.02 per unit of risk. If you would invest  134.00  in Neuropace on September 14, 2024 and sell it today you would earn a total of  957.00  from holding Neuropace or generate 714.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Neuropace  vs.  908 Devices

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.
908 Devices 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 908 Devices has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Neuropace and 908 Devices Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and 908 Devices

The main advantage of trading using opposite Neuropace and 908 Devices positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, 908 Devices can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 908 Devices will offset losses from the drop in 908 Devices' long position.
The idea behind Neuropace and 908 Devices pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.